The hemorrhagic stroke initiative aims to extend and improve patients’ lives
This American Heart Association® initiative, sponsored by Alexion Pharmaceuticals, addresses the need for improved identification and treatment of hemorrhagic stroke patients.
Set to launch later this year, the Hemorrhagic Stroke Initiative will evaluate new efforts to enhance the care of hemorrhagic stroke patients in hospitals and stroke centers across America.
Stroke is the No. 5 cause of death in the United States and a leading cause of disability. Hemorrhagic strokes make up roughly 10 percent of the nearly 800,000 strokes that occur annually, and they have a higher mortality rate than other types of stroke. Hemorrhagic stroke patients who are treated with novel oral anticoagulants, or NOACs, have an in-hospital mortality rate of 26.5%.
Phase Two Is Now Underway
We are currently working with a select group of dedicated stroke centers across the nation to improve hemorrhagic stroke care. These sites are leading the way to improve hemorrhagic stroke systems of care by aiding the development of targeted education that will standardize treatment protocols.
Please join our email list to stay up-to-date on all late-breaking info as it occurs.
Built on the foundation of Get With The Guidelines®
Get With The Guidelines is a hospital-based quality improvement program from the American Heart Association that provides tools and resources to increase adherence to the latest research-based guidelines. GWTG is based on the premise that when medical professionals apply the most up-to-date evidence-based treatment guidelines, patient outcomes improve.